APLI SRL
1.4 FTEThe score of APLI shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity -11 % Total assets -19 % Headcount (avg FTE) -59 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
APLI's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 79,445 € | ||||
| Equity | 173,520 € | ||||
| Cash | 134,170 € | ||||
| EBITDA | 156,545 € | ||||
| Total assets | 542,139 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
- Year ended 31 Dec 2020filed on 31 Aug 2021
APLI's financial analysis
- Solvency32.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of APLI
APLI's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.717.444
- VAT number
- BE0459717444
- Peppol
- Registered · 0208:0459717444 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Jan 1997
- Registered office
- 2060 Antwerp
- Size
- Micro · 1.4 FTE
- Latest accounts
- 2024 · filed on 07 Jul 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
APLI (SRL) has been based in Antwerp since 1997, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 79,445 € and equity of 173,520 €; its revenue is not published. With 1.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 32.0%, below the median of its sector (44.2%).
Companies similar to APLI
Companies in the same business, of comparable size and area, outside its group.
- @Venture VAN Praet Retail sale of pharmaceutical products Antwerp · balance sheet 968,620 €
- CCW Consulting Business and other management consultancy activities Seraing · balance sheet 490,756 €
- Berghman Business and other management consultancy activities Wervik · balance sheet 426,772 €
- North Flow Retail sale of pharmaceutical products Antwerp · balance sheet 303,640 €
- Pochet - DE Waleffe Retail sale of pharmaceutical products Gembloux · balance sheet 516,803 €
- Pharmaschmidt Retail sale of pharmaceutical products Liège · balance sheet 485,219 €
- Pharmacie DU Vert Chemin Retail sale of pharmaceutical products Nivelles · balance sheet 394,655 €
- Management Aelbers Retail sale of pharmaceutical products Dilsen-Stokkem · balance sheet €1.27m
Frequently asked questions about APLI
What is the revenue of APLI?
APLI files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of APLI?
In Belgium, the VAT number is the company number prefixed with BE: BE0459717444 for APLI, if the company is VAT-registered. Its company number (CBE) is 0459.717.444.
Where is the registered office of APLI?
According to the CBE register, the registered office of APLI is in 2060 Antwerp.
What is the equity of APLI?
At the close of the 2024 financial year, the equity of APLI amounts to 173,520 €, a solvency of 32.0% of total assets.
How many people work at APLI?
1.4 full-time equivalents on average according to the 2024 social balance sheet.
Who manages APLI?
The register lists 3 active mandates at APLI. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of APLI
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →